Lian Brian
SEC insider (Form 3/4/5 filer). CIK 0001614578. President & CEO at Viking Therapeutics, Inc. (VKTX). 20 reported Form 4/5 transactions since Sep 2024; latest on Jul 29, 2026. Located in SAN DIEGO, CA.
Companies Lian Brian has filed insider reports for
- Viking Therapeutics, Inc. (VKTX): Director, Officer, President & CEO
Lian Brian
CIK: 0001614578
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Viking Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (20 total)
- Jul 29, 2026VKTX
Viking Therapeutics, Inc.
SaleDirect148.5K shares at avg. $33.32$4.9M - Jul 28, 2026VKTX
Viking Therapeutics, Inc.
AwardDirect221.7K shares- - Jan 5, 2026VKTX
Viking Therapeutics, Inc.
SaleDirect53.3K shares at avg. $33.38$1.8M - Jan 5, 2026VKTX
Viking Therapeutics, Inc.
SaleDirect6.4K shares at avg. $35.07$224K - Jan 5, 2026VKTX
Viking Therapeutics, Inc.
SaleDirect41.3K shares at avg. $34.22$1.4M - Jan 5, 2026VKTX
Viking Therapeutics, Inc.
SaleDirect132.5K shares at avg. $32.29$4.3M - Jan 2, 2026VKTX
Viking Therapeutics, Inc.
AwardDirect78.4K shares- - Jan 2, 2026VKTX
Viking Therapeutics, Inc.
AwardDirect224.1K shares- - Oct 28, 2025VKTX
Viking Therapeutics, Inc.
SaleDirect39K shares at avg. $35.01$1.4M - Oct 27, 2025VKTX
Viking Therapeutics, Inc.
AwardDirect70.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 29, 2026 | VKTX Viking Therapeutics, Inc. | Sale | 148,517 | $33.32 | $4,947,888 | Direct |
| Jul 28, 2026 | VKTX Viking Therapeutics, Inc. | Award | 221,667 | - | $0 | Direct |
| Jan 5, 2026 | VKTX Viking Therapeutics, Inc. | Sale | 53,279 | $33.38 | $1,778,267 | Direct |
| Jan 5, 2026 | VKTX Viking Therapeutics, Inc. | Sale | 6,400 | $35.07 | $224,423 | Direct |
| Jan 5, 2026 | VKTX Viking Therapeutics, Inc. | Sale | 41,276 | $34.22 | $1,412,399 | Direct |
| Jan 5, 2026 | VKTX Viking Therapeutics, Inc. | Sale | 132,454 | $32.29 | $4,277,032 | Direct |
| Jan 2, 2026 | VKTX Viking Therapeutics, Inc. | Award | 78,400 | - | $0 | Direct |
| Jan 2, 2026 | VKTX Viking Therapeutics, Inc. | Award | 224,080 | - | $0 | Direct |
| Oct 28, 2025 | VKTX Viking Therapeutics, Inc. | Sale | 38,989 | $35.01 | $1,364,923 | Direct |
| Oct 27, 2025 | VKTX Viking Therapeutics, Inc. | Award | 70,084 | - | - | Direct |
1-10 of 20 transactions